← All trials
NCT07284511
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 5, 2026
- Primary completion
- Jan 31, 2028
- Completion date
- Jan 31, 2029
- First posted
- Dec 16, 2025
- Last posted
- Dec 16, 2025
- Enrollment
- 105
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- McGill UniversityLead sponsor
- Breakthrough T1DCollaborator
- University of BernCollaborator
- McGill UniversityCollaborator
- McGill UniversityOfficial
- McGill UniversitySponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.